Many people with COPD can control their symptoms by using inhaled medicines each day. But inhaled medicines may not offer enough relief for people who also have high levels of a type of white ...

Some of the most popular asthma and COPD inhalers are pictured. AstraZeneca's Symbicort, on the far right, uses greenhouse gases as its propellant. | Alamy Total revenue for the drug fell some 7 ...

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, discusses insights from the FLAME trial analysis and the ICS-RECODE meta-analysis.

Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...

So, the new label now warns that rare cases of pulmonary aspiration have been reported in patients taking GLP-1 medications ...

On Nov. 4 and 5, the FDA added a new warning to all approved GLP-1 medications. The drugs pose a risk of pulmonary aspiration during general anesthesia or deep sedation, according to rare ...

Chronic obstructive pulmonary disease is a serious, progressive illness that hits the homeless and underinsured the hardest.

This week Bobbi Conner talks with Dr. Charlie Strange about the diagnosis and treatment of COPD. Dr. Strange is a professor ...

CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening ...